NCT03295903View on ClinicalTrials.gov

Cannabinoid Supplementation on Vascular and Cognitive Function

EARLY_PHASE1UnknownINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

September 30, 2021

Study Completion Date

October 1, 2021

Conditions

Diet Modification

Interventions

DIETARY_SUPPLEMENT

Cannabidiol supplement

Subjects will be administered in a double-blinded, randomized and cross-over design

Trial Locations (1)

V1V 1V7

University of British Columbia, Kelowna

Sponsors

Collaborators (1)

Lexaria Bioscience Corp.

All Listed Sponsors

collaborator

Lexaria Bioscience Corp.

INDUSTRY

lead

University of British Columbia

OTHER

NCT03295903 - Cannabinoid Supplementation on Vascular and Cognitive Function | Biotech Hunter | Biotech Hunter